JHU395 T11717
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
JHU395 delivers 6-diazo-5-oxo-L-norleucine (DON) to malignant peripheral nerve sheath tumor (MPNST) in vitro and in vivo, and has antitumor activity in MPNST. JHU395 is an orally-bioavailable and a plasma stable lipophilic glutamine antagonists (GA) prodr
CAS nr:
2079938-92-2
Purity:
98%
Molecular Weight:
447,48
SMILES:
O=C(C(C)(C)C)OC(OC(N[C@@H](CCC(C=[N+]=[N-])=O)C(OC(C)C)=O)=O)C1=CC=CC=C1
Formula:
C22H29N3O7
Pathway:
Tyrosine Kinase/Adaptors,Angiogenesis,JAK/STAT signaling
Target:
EGFR,EGFR,EGFR
